Ftse Mib
38.158,74
-0,18%
DAX
22.672,23
0,29%
S&P 500
5.614,56
0,00%
NASDAQ
17.468,32
0,00%
Bitcoin
81.284,98
3,58%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TELA Bio Inc (TELA) TELA Bio Inc (TELA) Notizie

TELA Bio Inc

TELA
2,35
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 12:14:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202522:05GLOBETELA Bio to Announce Fourth Quarter and Full Year 2024..
25/2/202522:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202522:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202522:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
13/2/202518:07EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
12/2/202521:54EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
24/1/202522:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
13/12/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
19/11/202422:05GLOBETELA Bio to Participate in Piper Sandler’s 36th Annual..
07/11/202422:15EDGAR2Form 8-K - Current report
07/11/202422:05GLOBETELA Bio Reports Third Quarter 2024 Financial Results
01/11/202421:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
28/10/202421:06EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
24/10/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:05GLOBETELA Bio Announces Closing of Public Offering of Common..
23/10/202423:16EDGAR2Form 8-K - Current report
23/10/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/10/202414:07GLOBETELA Bio Announces Pricing of Public Offering of Common..
22/10/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/10/202422:05GLOBETELA Bio Announces Proposed Public Offering of Common Stock..
22/10/202422:01EDGAR2Form 8-K - Current report
17/10/202422:05GLOBETELA Bio to Announce Third Quarter 2024 Financial Results
13/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:15EDGAR2Form 8-K - Current report
12/8/202422:05GLOBETELA Bio Reports Second Quarter 2024 Financial Results and..
09/8/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
06/8/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202422:05GLOBETELA Bio to Participate in the Canaccord Genuity 44th Annual..
22/7/202422:05GLOBETELA Bio to Announce Second Quarter 2024 Financial Results
10/6/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/6/202422:15EDGAR2Form 8-K - Current report
04/6/202422:05GLOBETELA Bio Appoints Jeffrey Blizard to its Board of Directors
20/5/202422:15EDGAR2Form 8-K - Current report
20/5/202422:03GLOBETELA Bio Appoints Greg Firestone as Chief Commercial Officer
10/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:05GLOBETELA Bio Reports First Quarter 2024 Financial Results
25/4/202413:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15/4/202413:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08/4/202413:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
21/3/202421:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
Apertura: Min: Max:
Chiusura: 2,35

La tua Cronologia

NASDAQ
TELA
TELA Bio
NASDAQ
GBDC
Golub Capital BDC
NASDAQ
SCOR
comScore
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci